BIOMAT Database Logo BIOMAT Database Logo

Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. 1998

L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Unité de Pharmacologie Cellulaire-Unité Associée Pasteur/INSERM U 485, Institut Pasteur, Paris, France.

Lyso-phospholipids exert a major injurious effect on lung cell membranes during Acute Respiratory Distress Syndrome (ARDS), but the mechanisms leading to their in vivo generation are still unknown. Intratracheal administration of LPS to guinea pigs induced the secretion of type II secretory phospholipase A2 (sPLA2-II) accompanied by a marked increase in fatty acid and lyso-phosphatidylcholine (lyso-PC) levels in the bronchoalveolar lavage fluid (BALF). Administration of LY311727, a specific sPLA2-II inhibitor, reduced by 60% the mass of free fatty acid and lyso-PC content in BALF. Gas chromatography/mass spectrometry analysis revealed that palmitic acid and palmitoyl-2-lyso-PC were the predominant lipid derivatives released in BALF. A similar pattern was observed after the intratracheal administration of recombinant guinea pig (r-GP) sPLA2-II and was accompanied by a 50-60% loss of surfactant phospholipid content, suggesting that surfactant is a major lung target of sPLA2-II. In confirmation, r-GP sPLA2-II was able to hydrolyze surfactant phospholipids in vitro. This hydrolysis was inhibited by surfactant protein A (SP-A) through a direct and selective protein-protein interaction between SP-A and sPLA2-II. Hence, our study reports an in vivo direct causal relationship between sPLA2-II and early surfactant degradation and a new process of regulation for sPLA2-II activity. Anti-sPLA2-II strategy may represent a novel therapeutic approach in lung injury, such as ARDS.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008244 Lysophosphatidylcholines Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties. Lysolecithin,Lysolecithins,Lysophosphatidylcholine
D008297 Male Males
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011510 Proteolipids Protein-lipid combinations abundant in brain tissue, but also present in a wide variety of animal and plant tissues. In contrast to lipoproteins, they are insoluble in water, but soluble in a chloroform-methanol mixture. The protein moiety has a high content of hydrophobic amino acids. The associated lipids consist of a mixture of GLYCEROPHOSPHATES; CEREBROSIDES; and SULFOGLYCOSPHINGOLIPIDS; while lipoproteins contain PHOSPHOLIPIDS; CHOLESTEROL; and TRIGLYCERIDES.
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids

Related Publications

L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.
January 2012, American journal of physiology. Lung cellular and molecular physiology,
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.
January 2013, Surgery,
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Inhibition of lung calcium-independent phospholipase A2 by surfactant protein A.
September 1994, The American journal of physiology,
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase.
November 1989, The Biochemical journal,
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Inhibition of Trimeresurus flavoviridis phospholipase A2 by lung surfactant protein A (SP-A).
March 1994, Biochimica et biophysica acta,
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Regulation of lung surfactant secretion by phospholipase A2.
January 1999, Journal of cellular biochemistry,
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Effects of smoke inhalation on surfactant phospholipids and phospholipase A2 activity in the mouse lung.
January 1991, The American journal of pathology,
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis.
July 1997, Journal of immunology (Baltimore, Md. : 1950),
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Interaction of surfactant protein A with peroxiredoxin 6 regulates phospholipase A2 activity.
March 2006, The Journal of biological chemistry,
L Arbibe, and K Koumanov, and D Vial, and C Rougeot, and G Faure, and N Havet, and S Longacre, and B B Vargaftig, and G Béréziat, and D R Voelker, and C Wolf, and L Touqui
Secretory Phospholipase A2 Enzymes in Acute Lung Injury.
September 2021, Cell biochemistry and biophysics,
Copied contents to your clipboard!